BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24895061)

  • 1. HBP1 promoter methylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC.
    Tseng RC; Huang WR; Lin SF; Wu PC; Hsu HS; Wang YC
    J Cell Mol Med; 2014 Sep; 18(9):1752-61. PubMed ID: 24895061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All Trans-Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells.
    Lee MF; Hsieh NT; Huang CY; Li CI
    J Cell Physiol; 2016 Aug; 231(8):1796-803. PubMed ID: 26660958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression.
    Zhao L; Li S; Gan L; Li C; Qiu Z; Feng Y; Li J; Li L; Li C; Peng W; Xu C; Wang Z; Hui T; Ren G; Tao Q; Xiang T
    J Cell Mol Med; 2016 May; 20(5):842-54. PubMed ID: 26843424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPB41 suppresses the Wnt/β-catenin signaling in non-small cell lung cancer by sponging ALDOC.
    Yuan J; Xing H; Li Y; Song Y; Zhang N; Xie M; Liu J; Xu Y; Shen Y; Wang B; Zhang L; Yang M
    Cancer Lett; 2021 Feb; 499():255-264. PubMed ID: 33242559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA actin filament-associated protein 1 antisense RNA 1 promotes malignant phenotype through binding with lysine-specific demethylase 1 and repressing HMG box-containing protein 1 in non-small-cell lung cancer.
    Yu S; Yang D; Ye Y; Liu P; Chen Z; Lei T; Pu J; Liu L; Wang Z
    Cancer Sci; 2019 Jul; 110(7):2211-2225. PubMed ID: 31069893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
    Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
    EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.
    Chan CY; Huang SY; Sheu JJ; Roth MM; Chou IT; Lien CH; Lee MF; Huang CY
    Oncotarget; 2017 Feb; 8(9):14537-14548. PubMed ID: 28099936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-13 is a target gene of high-mobility group box-containing protein 1 in modulating oral cancer cell invasion.
    Chan CY; Lin TY; Sheu JJ; Wu WC; Huang CY
    J Cell Physiol; 2019 Apr; 234(4):4375-4384. PubMed ID: 30191992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis.
    Chen Y; Pan K; Wang P; Cao Z; Wang W; Wang S; Hu N; Xue J; Li H; Jiang W; Li G; Zhang X
    J Biol Chem; 2016 Jun; 291(24):12688-12705. PubMed ID: 27129219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathways.
    Bollaert E; de Rocca Serra A; Demoulin JB
    Cell Mol Life Sci; 2019 Apr; 76(8):1529-1539. PubMed ID: 30683982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
    Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
    Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1.
    You W; Chen B; Liu X; Xue S; Qin H; Jiang H
    Sci Rep; 2017 Apr; 7(1):591. PubMed ID: 28377627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis.
    Tseng RC; Lin RK; Wen CK; Tseng C; Hsu HS; Hsu WH; Wang YC
    Oncogene; 2008 Jul; 27(32):4488-96. PubMed ID: 18372914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer.
    Li XQ; Yang XL; Zhang G; Wu SP; Deng XB; Xiao SJ; Liu QZ; Yao KT; Xiao GH
    J Transl Med; 2013 May; 11():114. PubMed ID: 23648139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-155 promotes colitis-associated intestinal fibrosis by targeting HBP1/Wnt/β-catenin signalling pathway.
    Li N; Ouyang Y; Xu X; Yuan Z; Liu C; Zhu Z
    J Cell Mol Med; 2021 May; 25(10):4765-4775. PubMed ID: 33769664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma.
    Malik SA; Khan MS; Dar M; Hussain MU; Shah MA; Shafi SM; Mudassar S
    Pathol Oncol Res; 2018 Apr; 24(2):207-214. PubMed ID: 28434174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulated NRIP2 in colorectal cancer initiating cells modulates the Wnt pathway by targeting RORβ.
    Wen Z; Pan T; Yang S; Liu J; Tao H; Zhao Y; Xu D; Shao W; Wu J; Liu X; Wang Y; Mao J; Zhu Y
    Mol Cancer; 2017 Jan; 16(1):20. PubMed ID: 28137278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1.
    Kim J; Zhang X; Rieger-Christ KM; Summerhayes IC; Wazer DE; Paulson KE; Yee AS
    J Biol Chem; 2006 Apr; 281(16):10865-75. PubMed ID: 16495219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.